September 15, 2012 l Beijing Headquarters

  • Dr. Jos Brands, Merck Research Laboratories, US 
  • Prof. Liu-Zhu Gong, University of Science and Technology, China 
  • Prof. Shengming Ma, East China Normal University & SIOC, China 
  • Prof. Greg Fu, California Institute of Technology, US 
  • Dr. Luigi La Vecchia, Novartis Pharma AG, Switzerland 
  • Prof. Brian Stolz, California Institute of Technology, US